Nestl \u00e9 Health Science

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 4, 2018	ENTEROME	$86.7M Debt / Series D	—	Paul Biondi, Ambroise Fayolle, Health for Life Capital, Lundbeckfond Ventures, Omnes Capital, Paolo Daniele Siviero
Apr 1, 2016	ENTEROME	$16.0M Series C	Seventure Partners, Lundbeckfond Ventures	Edward Van Wezel, Forbion, Novartis Venture Fund, Greg Behar

Total Raised

N/A

Valuation

N/A